| 03.05.2024 09:06:50 | |
|---|---|
| Cena | |
| 231,95 EUR | |
| Změna | 1,75% (4,00) |
Základní údaje
| ISIN | US2358511028 |
| Symbol | DHR |
| Burza | Xetra |
| Měna | EUR |
| Sektor | Other |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 170.394 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 228,70 EUR (13) |
| Prodej (částka) | 230,05 EUR (72) |
| Otevírací cena | 231,95 EUR |
| Max | 231,95 EUR |
| Min | 231,95 EUR |
| Závěrečná cena (předchozí den) | 227,95 EUR |
| Cena vážená obchodovaným objemem | 231,95 EUR |
| Objem (kusy) | 1 |
| Obchodovaný objem | 231,95 |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | 1 |
Futures a opce
| Související Futures | - |
| Související Opce | - |
PDF ke stažení
| Report společnosti: DANAHER CORP. |  |
Přidat benchmark:
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 26.04.2024 |
|
Global Equity Ratings |
|
| 03.04.2024 |
|
Global Equity Ratings |
|
| 13.03.2024 |
|
Global Equity Ratings |
|
| 22.02.2024 |
|
Global Equity Ratings |
|
| 14.02.2024 |
|
Global Equity Ratings |
|
Všechny burzy pro DANAHER CORP.
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 03.05.2024 | 09:06 | 231,95 EUR | 0,00 | 1 |
| Vienna Stock Exchange | 02.05.2024 | 17:32 | 227,80 EUR | 0,00 | 2 |
| Tradegate | 03.05.2024 | 10:13 | 229,50 EUR | 0,18 | 14 |
| Stuttgart | 03.05.2024 | 08:02 | 230,85 EUR | 0,00 | 1 |
| NYSE | 02.05.2024 | 22:00 | 246,84 USD | 683,61 | 39.567 |
| Munich | 03.05.2024 | 08:05 | 230,80 EUR | 0,00 | 1 |
| London Stock Exchange | 30.04.2024 | 15:30 | 246,50 USD | 0,42 | 1 |
| Hanover | 03.05.2024 | 08:00 | 230,85 EUR | 0,00 | 1 |
| Frankfurt | 03.05.2024 | 08:00 | 230,85 EUR | 0,00 | 1 |
| Euronext Milan MTF Trading After Hours | - | - | - | 0,00 | - |
| Euronext Milan MTF Global Equity Market | 02.05.2024 | 17:44 | 228,60 EUR | 0,00 | 1 |
| Duesseldorf | 03.05.2024 | 09:30 | 228,75 EUR | 0,00 | 2 |
| Berlin | 03.05.2024 | 08:05 | 230,80 EUR | 0,00 | 1 |
| 03.05.2024 09:06:50 | |
|---|---|
| Cena | |
| 231,95 EUR | |
| Změna | 1,75% (4,00) |
Základní údaje
| ISIN | US2358511028 |
| Symbol | DHR |
| Burza | Xetra |
| Měna | EUR |
| Sektor | Other |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 170.394 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 228,70 EUR (13) |
| Prodej (částka) | 230,05 EUR (72) |
| Otevírací cena | 231,95 EUR |
| Max | 231,95 EUR |
| Min | 231,95 EUR |
| Závěrečná cena (předchozí den) | 227,95 EUR |
| Cena vážená obchodovaným objemem | 231,95 EUR |
| Objem (kusy) | 1 |
| Obchodovaný objem | 231,95 |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | 1 |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | +25,80% | +18,61% | +22,09% |
| Výkonn. (abs.) | +46,75 | +35,76 | +41,24 |
| Beta | 0,97 | 0,78 | 0,95 |
| Volatilita | 22,77 | 22,40 | 25,80 |
Přidat benchmark:
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 230,22 EUR (609) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 228,66 EUR (718) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 222,80 EUR (604) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 207,77 EUR (742) |
| YTD Max| datum | 240,95 EUR (23.04.2024) |
| YTD Min | datum | 204,90 EUR (15.01.2024) |
| 52týdenní max. | datum | 240,95 EUR (23.04.2024) |
| 52týdenní min. | datum | 172,40 EUR (30.10.2023) |
Logo společnosti
Kontakty
| DANAHER CORP. |
| - - |
| 2200 Pennsylvania Avenue North West, Suite 800 West - 20037-1701 Washington |
| Telefon:+1-202-828-0850 |
| Fax:+1-202-828-0860 |
| E-mail:- |
PDF ke stažení
| Report společnosti: DANAHER CORP. | |
Profil společnosti
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC. |
Členové představenstva
| Steven Rales | Chairman of Board of Directors |
| Elias Zerhouni | Member of Board of Directors |
| Jessica Mega | Member of Board of Directors |
| Pardis Sabeti | Member of Board of Directors |
| Raymond Stevens | Member of Board of Directors |
| A. Sanders | Member of Board of Directors |
| Alan Spoon | Member of Board of Directors |
| Feroz Dewan | Member of Board of Directors |
| John Schwieters | Member of Board of Directors |
| Linda Filler | Member of Board of Directors |
| Mitchell Rales | Member of Board of Directors |
| Teri List-Stoll | Member of Board of Directors |
| Walter Lohr | Member of Board of Directors |
| Rainer Blair | Chairman of Managing Board |
| Brian Ellis | Member of Executive Committee |
| Chris Riley | Member of Executive Committee |
| Daniel Raskas | Member of Executive Committee |
| Georgeann Couchara | Member of Executive Committee |
| Joakim Weidemanis | Member of Executive Committee |
| Jose-Carlos Gutierrez-Ramos | Member of Executive Committee |
| Matt McGrew | Member of Executive Committee |
| William H. King, IV | Member of Executive Committee |